BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33983594)

  • 21. A clinically structured and partnered approach to genetic testing in Trinidadian women with breast cancer and their families.
    Donenberg T; George S; Ali J; Bravo G; Hernandez K; Sookar N; Ashing KT; Narod SA; Akbari MR; Hurley J
    Breast Cancer Res Treat; 2019 Apr; 174(2):469-477. PubMed ID: 30515680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Initial Results of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer and Lynch Syndrome.
    Howarth DR; Lum SS; Esquivel P; Garberoglio CA; Senthil M; Solomon NL
    Am Surg; 2015 Oct; 81(10):941-4. PubMed ID: 26463285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene panel testing for inherited cancer risk.
    Hall MJ; Forman AD; Pilarski R; Wiesner G; Giri VN
    J Natl Compr Canc Netw; 2014 Sep; 12(9):1339-46. PubMed ID: 25190699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rescreening for genetic mutations using multi-gene panel testing in patients who previously underwent non-informative genetic screening.
    Frey MK; Kim SH; Bassett RY; Martineau J; Dalton E; Chern JY; Blank SV
    Gynecol Oncol; 2015 Nov; 139(2):211-5. PubMed ID: 26296696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
    ; Owens DK; Davidson KW; Krist AH; Barry MJ; Cabana M; Caughey AB; Doubeni CA; Epling JW; Kubik M; Landefeld CS; Mangione CM; Pbert L; Silverstein M; Simon MA; Tseng CW; Wong JB
    JAMA; 2019 Aug; 322(7):652-665. PubMed ID: 31429903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?
    Eliade M; Skrzypski J; Baurand A; Jacquot C; Bertolone G; Loustalot C; Coutant C; Guy F; Fumoleau P; Duffourd Y; Arnould L; Delignette A; Padéano MM; Lepage C; Raichon-Patru G; Boudrant A; Bône-Lépinoy MC; Villing AL; Charpin A; Peignaux K; Chevrier S; Vegran F; Ghiringhelli F; Boidot R; Sevenet N; Lizard S; Faivre L
    Oncotarget; 2017 Jan; 8(2):1957-1971. PubMed ID: 27779110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Management of Patients at Risk for Hereditary Breast Cancer with Variants of Uncertain Significance in the Era of Multigene Panel Testing.
    Chang J; Seng S; Yoo J; Equivel P; Lum SS
    Ann Surg Oncol; 2019 Oct; 26(10):3389-3396. PubMed ID: 31342386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer Susceptibility Genetic Testing in a High-Risk Cohort of Urban Ashkenazi Jewish Individuals.
    Nielsen SM; De Simone LM; Olopade OI
    J Genet Couns; 2018 Dec; 27(6):1405-1410. PubMed ID: 29946849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multi-gene panel study in hereditary breast and ovarian cancer in Colombia.
    Cock-Rada AM; Ossa CA; Garcia HI; Gomez LR
    Fam Cancer; 2018 Jan; 17(1):23-30. PubMed ID: 28528518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How Have Multigene Panels Changed the Clinical Practice of Genetic Counseling and Testing.
    Pilarski R
    J Natl Compr Canc Netw; 2021 Jan; 19(1):103-108. PubMed ID: 33406496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Perils of Single-Site Genetic Testing for Hereditary Cancer Syndromes in the Era of Next-Generation Sequencing.
    Casasanta N; Stark E; McHenry A; Biagi T; Kaltman R
    Oncologist; 2018 Apr; 23(4):393-396. PubMed ID: 29445031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multi-gene panel testing for hereditary cancer susceptibility in a rural Familial Cancer Program.
    Hermel DJ; McKinnon WC; Wood ME; Greenblatt MS
    Fam Cancer; 2017 Jan; 16(1):159-166. PubMed ID: 27401692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Clinical Utility of Next Generation Sequencing Results in a Community-Based Hereditary Cancer Risk Program.
    Bunnell AE; Garby CA; Pearson EJ; Walker SA; Panos LE; Blum JL
    J Genet Couns; 2017 Feb; 26(1):105-112. PubMed ID: 27276934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development, technical validation, and clinical application of a multigene panel for hereditary gastrointestinal cancer and polyposis.
    Ricci MT; Volorio S; Signoroni S; Mariani P; Mariette F; Sardella D; Pensotti V; Vitellaro M
    Tumori; 2019 Aug; 105(4):338-352. PubMed ID: 31068090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer Genetic Counseling and Testing in an Era of Rapid Change.
    Hooker GW; Clemens KR; Quillin J; Vogel Postula KJ; Summerour P; Nagy R; Buchanan AH
    J Genet Couns; 2017 Dec; 26(6):1244-1253. PubMed ID: 28434142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and testing of the KnowGene scale to assess general cancer genetic knowledge related to multigene panel testing.
    Underhill-Blazey M; Stopfer J; Chittenden A; Nayak MM; Lansang K; Lederman R; Garber J; Gundersen DA
    Patient Educ Couns; 2019 Aug; 102(8):1558-1564. PubMed ID: 31010603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Updates on breast cancer genetics: Clinical implications of detecting syndromes of inherited increased susceptibility to breast cancer.
    Cobain EF; Milliron KJ; Merajver SD
    Semin Oncol; 2016 Oct; 43(5):528-535. PubMed ID: 27899183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hereditary breast cancer syndromes and genetic testing.
    Rich TA; Woodson AH; Litton J; Arun B
    J Surg Oncol; 2015 Jan; 111(1):66-80. PubMed ID: 25381882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How to facilitate psychosocial adjustment in women tested for hereditary breast or ovarian cancer susceptibility? Insights from network analysis.
    Brédart A; Dick J; Cano A; Robieux L; De Pauw A; Schmutzler R; Stoppa-Lyonnet D; Dolbeault S; Kop JL
    Psychooncology; 2020 Mar; 29(3):550-556. PubMed ID: 31823434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic yield of multigene panel testing in an Israeli cohort: enrichment of low-penetrance variants.
    Bernstein-Molho R; Friedman E; Kedar I; Laitman Y; Allweis TM; Gal-Yam EN; Feldman HB; Grinshpun A; Halpern N; Hartmajer S; Kadouri L; Katz LH; Kaufman B; Laish I; Levanon K; Philipsborn SL; Ludman M; Moran G; Peretz T; Reinstein E; Levi GR; Safra T; Shkedi S; Vinkler C; Levy Z; Goldberg Y
    Breast Cancer Res Treat; 2020 Jun; 181(2):445-453. PubMed ID: 32303989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.